| Previous Close | 0.3800 |
| Open | 0.3700 |
| Bid | 0.3550 x 0 |
| Ask | 0.3850 x 0 |
| Day's Range | 0.3400 - 0.3900 |
| 52 Week Range | 0.1900 - 0.5600 |
| Volume | 269,806 |
| Avg. Volume | 150,327 |
| Market Cap | 79.681M |
| Beta (5Y Monthly) | -0.20 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0130 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec. 27, 2006 |
| 1y Target Est | N/A |
- CNW Group
/R E P E A T -- Sirona Biochem Reports Excellent Results in New Clinical Study on TFC-1067/
Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (US-OTC: SRBCF) ("Sirona") is pleased to announce that the second clinical trial of the active ingredient, TFC-1067, has been completed with excellent results.
- CNW Group
Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067
VANCOUVER, BC, March 10, 2021 /CNW/ - Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (US-OTC: SRBCF) is pleased to announce the launch of the first commercial product containing the Company's proprietary ingredient, TFC-1067.
- CNW Group
/R E P E A T -- Sirona Biochem CEO Quarterly Update Q1 2021/
24, 2021 /CNW/ - Sirona Biochem Corp. (TSXV: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") is pleased to provide the following update to shareholders.
© 2021 Verizon Media. All rights reserved.
